{"entity":{"type":"insider","cik":"0001585839","url":"/insider/0001585839","json_url":"/insider/0001585839.json","name":"PFREUNDSCHUH PETER P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":14,"first":"2019-08-22","last":"2024-02-22","span_basis":"filed_date"},"name_variants":[{"name":"PFREUNDSCHUH PETER P.","source":"filing","n_filings":14,"first_seen":"2019-08-22","last_seen":"2024-02-22"}],"transactions":[{"id":2128821,"accession":"0001104659-24-026556","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-026556","line_url":"/filing/0001104659-24-026556#line-1","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3764.0,"shares_display":"3,764","price_per_share":7.46,"price_display":"7.46","price_state":"stated","total_value":28079.44,"total_display":"28,079.44","total_whole":"28,079","shares_owned_after":175669.0,"shares_owned_after_display":"175,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-21","filed_date":"2024-02-22","scope":"insider"},{"id":8357637,"accession":"0001104659-23-107217","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-107217","line_url":"/filing/0001104659-23-107217#line-1","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13567.0,"shares_display":"13,567","price_per_share":6.99,"price_display":"6.99","price_state":"stated","total_value":94833.33,"total_display":"94,833.33","total_whole":"94,833","shares_owned_after":149433.0,"shares_owned_after_display":"149,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-05","scope":"insider"},{"id":6719264,"accession":"0001127602-22-006327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-006327","line_url":"/filing/0001127602-22-006327#line-2","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1542.0,"shares_display":"1,542","price_per_share":3.529,"price_display":"3.53","price_state":"stated","total_value":5441.718,"total_display":"5,441.72","total_whole":"5,442","shares_owned_after":8927.0,"shares_owned_after_display":"8,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-22","filed_date":"2022-02-23","scope":"insider"},{"id":6719260,"accession":"0001127602-22-006327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-006327","line_url":"/filing/0001127602-22-006327#line-1","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1404.0,"shares_display":"1,404","price_per_share":3.877,"price_display":"3.88","price_state":"stated","total_value":5443.308,"total_display":"5,443.31","total_whole":"5,443","shares_owned_after":10469.0,"shares_owned_after_display":"10,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-23","scope":"insider"},{"id":6576458,"accession":"0001127602-22-005755","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-005755","line_url":"/filing/0001127602-22-005755#line-2","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1296.0,"shares_display":"1,296","price_per_share":4.2,"price_display":"4.20","price_state":"stated","total_value":5443.2,"total_display":"5,443.20","total_whole":"5,443","shares_owned_after":11873.0,"shares_owned_after_display":"11,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-17","filed_date":"2022-02-18","scope":"insider"},{"id":6576454,"accession":"0001127602-22-005755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-005755","line_url":"/filing/0001127602-22-005755#line-1","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1229.0,"shares_display":"1,229","price_per_share":4.429,"price_display":"4.43","price_state":"stated","total_value":5443.241,"total_display":"5,443.24","total_whole":"5,443","shares_owned_after":13169.0,"shares_owned_after_display":"13,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":6649282,"accession":"0001127602-22-005327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-005327","line_url":"/filing/0001127602-22-005327#line-2","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1347.0,"shares_display":"1,347","price_per_share":4.331,"price_display":"4.33","price_state":"stated","total_value":5833.857,"total_display":"5,833.86","total_whole":"5,834","shares_owned_after":14398.0,"shares_owned_after_display":"14,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-15","filed_date":"2022-02-16","scope":"insider"},{"id":3047135,"accession":"0001209191-20-055037","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-055037","line_url":"/filing/0001209191-20-055037","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":21.769895541666667,"price_display":"21.77","price_state":"stated","total_value":52247.7493,"total_display":"52,247.75","total_whole":"52,248","shares_owned_after":10405.0,"shares_owned_after_display":"10,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-15","filed_date":"2020-10-16","scope":"insider","n_lines":3},{"id":2557566,"accession":"0001209191-20-048883","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-048883","line_url":"/filing/0001209191-20-048883#line-2","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":509.0,"shares_display":"509","price_per_share":22.82,"price_display":"22.82","price_state":"stated","total_value":11615.38,"total_display":"11,615.38","total_whole":"11,615","shares_owned_after":7888.0,"shares_owned_after_display":"7,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-01","scope":"insider"},{"id":2900746,"accession":"0001209191-20-043874","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-043874","line_url":"/filing/0001209191-20-043874#line-2","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":141.0,"shares_display":"141","price_per_share":23.51,"price_display":"23.51","price_state":"stated","total_value":3314.91,"total_display":"3,314.91","total_whole":"3,315","shares_owned_after":7355.0,"shares_owned_after_display":"7,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-27","filed_date":"2020-07-28","scope":"insider"},{"id":3166371,"accession":"0001209191-20-030900","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-030900","line_url":"/filing/0001209191-20-030900#line-2","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":358.0,"shares_display":"358","price_per_share":25.07,"price_display":"25.07","price_state":"stated","total_value":8975.06,"total_display":"8,975.06","total_whole":"8,975","shares_owned_after":7079.0,"shares_owned_after_display":"7,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-20","filed_date":"2020-05-20","scope":"insider"},{"id":2782043,"accession":"0001209191-20-025903","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-025903","line_url":"/filing/0001209191-20-025903#line-2","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":141.0,"shares_display":"141","price_per_share":24.35,"price_display":"24.35","price_state":"stated","total_value":3433.35,"total_display":"3,433.35","total_whole":"3,433","shares_owned_after":6396.0,"shares_owned_after_display":"6,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-27","filed_date":"2020-04-28","scope":"insider"},{"id":2367395,"accession":"0001209191-20-012017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-012017","line_url":"/filing/0001209191-20-012017#line-2","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":360.0,"shares_display":"360","price_per_share":29.68,"price_display":"29.68","price_state":"stated","total_value":10684.8,"total_display":"10,684.80","total_whole":"10,685","shares_owned_after":6120.0,"shares_owned_after_display":"6,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-20","filed_date":"2020-02-24","scope":"insider"},{"id":2709842,"accession":"0001209191-20-005215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-005215","line_url":"/filing/0001209191-20-005215#line-2","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":667.0,"shares_display":"667","price_per_share":29.28,"price_display":"29.28","price_state":"stated","total_value":19529.76,"total_display":"19,529.76","total_whole":"19,530","shares_owned_after":4438.0,"shares_owned_after_display":"4,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-28","scope":"insider"},{"id":7928984,"accession":"0001209191-19-057753","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-057753","line_url":"/filing/0001209191-19-057753#line-2","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":354.0,"shares_display":"354","price_per_share":28.41,"price_display":"28.41","price_state":"stated","total_value":10057.14,"total_display":"10,057.14","total_whole":"10,057","shares_owned_after":3439.0,"shares_owned_after_display":"3,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-22","scope":"insider"},{"id":7979914,"accession":"0001209191-19-047107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-047107","line_url":"/filing/0001209191-19-047107#line-2","is_derivative":false,"issuer_cik":"0001585839","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001585839","owner_cik":"0001585839","owner_name":"PFREUNDSCHUH PETER P.","owner_display_name":"PFREUNDSCHUH PETER P.","owner_url":"/insider/0001585839","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1416.0,"shares_display":"1,416","price_per_share":33.07,"price_display":"33.07","price_state":"stated","total_value":46827.12,"total_display":"46,827.12","total_whole":"46,827","shares_owned_after":2751.0,"shares_owned_after_display":"2,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001640266","name":"Voyager Therapeutics, Inc.","url":"/issuer/0001640266","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2023-10-05","last_seen":"2024-02-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001703647","name":"Frequency Therapeutics, Inc.","url":"/issuer/0001703647","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2022-02-16","last_seen":"2022-02-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001668243","name":"UroGen Pharma Ltd.","url":"/issuer/0001668243","role":"Officer (Chief Financial Officer)","n_filings":9,"first_seen":"2019-08-22","last_seen":"2020-10-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001585839","retrieved_at":"2026-08-23T12:30:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}